Phase I/II and pharmacokinetic study of combination chemotherapy with S-1 and oxaliplatin in patients with previously untreated metastatic or recurrent gastric cancer

被引：0

作者：

Park, I. ^{[1
]}

Lee, J. ^{[1
]}

Ryu, M. ^{[1
]}

Chang, H. ^{[1
]}

Kim, T. ^{[1
]}

Sym, S. ^{[1
]}

Lee, S. ^{[1
]}

Jang, G. ^{[1
]}

Bae, K. ^{[1
]}

Kang, Y. ^{[1
]}

机构：

[1] Asan Med Ctr, Seoul, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.4557

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4557

引用

页数：1

共 50 条

[31] Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer
Takayama, T.
Sato, Y.
Sagawa, T.
Okamoto, T.
Nagashima, H.
Takahashi, Y.
Ohnuma, H.
Kuroiwa, G.
Miyanishi, K.
Takimoto, R.
Matsunaga, T.
Kato, J.
Yamaguchi, K.
Hirata, K.
Niitsu, Y.
BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 851 - 856
[32] A phase II trial of gemcitabine in combination with oxaliplatin and capecitabine in previously untreated metastatic or recurrent pancreatic cancer
Sym, Sun Jin
Hong, Junsik
Jung, Minkyu
Koo, Yang Seo
Park, Yeon Ho
Kim, Koen Kook
Park, Jinny
Cho, Eun Kyung
Lee, Jae Hoon
Shin, Dongbok
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
[33] Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis
Junshik Hong
Sae-Won Han
Hye Seon Ham
Tae-Yong Kim
In Sil Choi
Byung-Su Kim
Do-Youn Oh
Seock-Ah Im
Gyeong Hoon Kang
Yung-Jue Bang
Tae-You Kim
Cancer Chemotherapy and Pharmacology, 2011, 67 : 1323 - 1331
[34] Phase II study of biweekly S-1 and oxaliplatin combination chemotherapy in metastatic colorectal cancer and pharmacogenetic analysis
Hong, Junshik
Han, Sae-Won
Ham, Hye Seon
Kim, Tae-Yong
Choi, In Sil
Kim, Byung-Su
Oh, Do-Youn
Im, Seock-Ah
Kang, Gyeong Hoon
Bang, Yung-Jue
Kim, Tae-You
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1323 - 1331
[35] A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
Kentaro Yamazaki
Hiroyuki Kuwano
Hitoshi Ojima
Toshio Otsuji
Takeshi Kato
Ken Shimada
Ichinosuke Hyodo
Tomohiro Nishina
Kuniaki Shirao
Taito Esaki
Takashi Ohishi
Tadamichi Denda
Masahiro Takeuchi
Narikazu Boku
Cancer Chemotherapy and Pharmacology, 2015, 75 : 569 - 577
[36] PHASE 1 DOSE-FINDING STUDY OF EPIRUBICIN, OXALIPLATIN, AND S-1 IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED GASTRIC CANCER
Sym, S. J.
Hong, J.
Lee, G. B.
Cho, E. K.
Lee, W. K.
Chung, M.
Park, Y. H.
Shin, D. B.
EJC SUPPLEMENTS, 2011, 9 (01): : 15 - 16
[37] A randomized phase II study of combination therapy with S-1, oral leucovorin, and oxaliplatin (SOL) and mFOLFOX6 in patients with previously untreated metastatic colorectal cancer
Yamazaki, Kentaro
Kuwano, Hiroyuki
Ojima, Hitoshi
Otsuji, Toshio
Kato, Takeshi
Shimada, Ken
Hyodo, Ichinosuke
Nishina, Tomohiro
Shirao, Kuniaki
Esaki, Taito
Ohishi, Takashi
Denda, Tadamichi
Takeuchi, Masahiro
Boku, Narikazu
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 569 - 577
[38] Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer
Kawabata, Ryohei
Fujiwara, Yoshiyuki
Doki, Yuichiro
Fujita, Junya
Tsukahara, Yasuo
Yamasaki, Makoto
Miyata, Hiroshi
Takiguchi, Shuji
Monden, Morito
ONCOLOGY, 2007, 72 (3-4) : 219 - 225
[39] Phase II study with oxaliplatin and S-1 for patients with metastatic colorectal cancer
Zang, D. Y.
Lee, B. H.
Park, H. -C.
Song, H. H.
Kim, H. J.
Jung, J. Y.
Kim, J. H.
Kim, H. Y.
Kwon, J. H.
Hwang, S. W.
Park, S. R.
Park, C. H.
Kim, K. O.
Kim, M. -J.
Jang, K. M.
ANNALS OF ONCOLOGY, 2009, 20 (05) : 892 - 896
[40] Phase I dose-finding study of epirubicin, oxaliplatin, and S-1 (EOS) in patients with previously untreated advanced gastric cancer (AGC)
Sym, S.
Hong, J.
Park, J.
Cho, E.
Lee, W.
Chung, M.
Park, Y.
Lee, J.
Shin, D.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)

← 1 2 3 4 5 →